¼¼°èÀÇ ½ÉÀå °á¼Õ Æó¼â ±â±â ½ÃÀå º¸°í¼­(2025³â)
Heart Defect Closure Device Global Market Report 2025
»óǰÄÚµå : 1704505
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,387,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,232,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,077,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

½ÉÀå °á¼Õ Æó¼â ±â±â ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö ¿¬Æò±Õ 14.2%ÀÇ ¼ºÀå·ü·Î 21¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº ¼±Ãµ¼º °á¼ÕÀÇ Áõ°¡, Áø´Ü ±â¼úÀÇ Çâ»ó, MRI ½Ã¼úÀÇ Ã¤Åà Áõ°¡, ½ÉÀå °á¼Õ Æó¼â¼ú¿¡¼­ 3D À̹Ì¡ÀÇ »ç¿ë Áõ°¡, ÇãÇ÷¼º ³úÁ¹ÁßÀÇ ³ôÀº ¹ß»ý·ü¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ±â¼ú ¹ßÀü, Çõ½ÅÀûÀÎ Á¦Ç° °³¹ß, Â÷¼¼´ë ½ÉÀå Æó¼â ±â±â °³¹ß, PFO Æó¼â ±â±â °ËÃâ Áõ°¡, ³ëÀÎ Àα¸¿¡ ´ëÇÑ PFO Æó¼âÀÇ ÀÌÁ¡À» Æò°¡ÇÒ Çʿ伺 µîÀÌ ÀÖ½À´Ï´Ù.

¼±Ãµ¼º ½ÉÀå ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È ½ÉÀå °á¼Õ Æó¼â ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼±Ãµ¼º ½ÉÀåÁúȯÀº ¼±ÃµÀûÀ¸·Î Á¸ÀçÇÏ´Â ½ÉÀåÀÇ ±¸Á¶Àû °áÇÔÀÔ´Ï´Ù. ¼±Ãµ¼º ½ÉÀå ÁúȯÀÇ Áõ°¡´Â À¯ÀüÀû ¼ÒÀÎ, ȯ°æÀû ¿µÇâ, ´ç´¢º´, ºñ¸¸, ÀӽŠÁß Æ¯Á¤ ¾à¹° ¹× °¨¿°¿¡ ´ëÇÑ ³ëÃâ°ú °°Àº »ê¸ðÀÇ °Ç°­ »óÅÂ¿Í °°Àº ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ½ÉÀå °á¼Õ Æó¼â ±â±â´Â ºñÁ¤»óÀûÀÎ ½ÉÀå °³±¸ºÎ¸¦ ¸·°í, Á¤»óÀûÀÎ Ç÷·ù¸¦ ȸº¹Çϰí, ÇÕº´ÁõÀ» ÁÙÀ̰í, Àü¹ÝÀûÀÎ ½ÉÀå ±â´ÉÀ» °­È­ÇÔÀ¸·Î½á ÀÌ·¯ÇÑ »óŸ¦ Ä¡·áÇÏ´Â ÃÖ¼Òħ½ÀÀû ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 10¿ù ¹Ì±¹ »ýÀÇÇÐ ¿¬±¸±â°üÀÎ ±¹¸³ÀÇÇеµ¼­°ü(NLM)¿¡ °ÔÀçµÈ ³í¹®¿¡ µû¸£¸é ¼±Ãµ¼º ½ÉÀ庴(CHD) ¹ßº´·üÀº 2020³â 1.12%, 2021³â 2.36%, 2022³â 3.87%¿¡¼­ 2023³â¿¡´Â 5.46%·Î ±ÞÁõÇÒ °ÍÀ¸·Î º¸°í º¸°íµÇ°í ÀÖ½À´Ï´Ù. ±× °á°ú, ¼±Ãµ¼º ½ÉÀ庴 ȯÀÚÀÇ Áõ°¡°¡ ½ÉÀå °á¼Õ Æó¼â ±â±â ½ÃÀå È®´ë¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

½ÉÀå °á¼Õ Æó¼â ±â±â ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº ÀÚ°¡ È®ÀåÇü ÀÌÁß µð½ºÅ© ¿ÀŬ·ç´õ¸¦ °³¹ßÇÏ¿© ½ÉÀå °á¼ÕÀ» ¸·´Â ÃÖ¼Òħ½ÀÀû ¼Ö·ç¼ÇÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æó¼â¼úÀº ½Ã¼úÀÇ ¾ÈÀü¼ºÀ» ³ôÀ̰í ȸº¹ ½Ã°£À» ´ÜÃàÇÏ¿© ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϸç, ±âÁ¸ °³½É¼ú°ú °ü·ÃµÈ ÇÕº´ÁõÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ÀÇ ÀÇ·á±â±â ¹× ÇコÄÉ¾î ±â¾÷ÀÎ Abbott Laboratories´Â 2022³â 9¿ù À¯·´¿¡¼­ Amplatzer Talisman PFO Occlusion SystemÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ±â±â´Â ³úÁ¹Áß ¹× ±âŸ ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ´Â ½ÉÀåÀÇ ÁÂ¿ì ½É¹æ »çÀÌÀÇ ºñÁ¤»óÀûÀÎ °³±¸ºÎÀÎ ½É¹æ¼¼µ¿(PFO)À» Æó¼âÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ´ÏƼ³î ¿ÍÀÌ¾î ¸Þ½Ã·Î ¸¸µç ÀÚ°¡ È®ÀåÇü ÀÌÁß µð½ºÅ© ¿ÀŬ·ç´õ¸¦ Àü°³ÇÏ´Â ÃÖ¼Òħ½ÀÀû ½Ã¼úÀ» ÅëÇØ PFO¸¦ È¿°úÀûÀ¸·Î Æó¼âÇÏ°í ½É¹æ »çÀÌÀÇ Ç÷ÀüÀÌ Åë°úÇÏ´Â °ÍÀ» ¹æÁöÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ, ±×¸®°í °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

A heart defect closure device is a medical instrument designed to close abnormal openings or defects in the heart's structure, particularly in the septum, the wall that separates the heart's chambers. These devices are used to treat specific heart conditions, such as atrial septal defects or patent foramen ovale, by sealing the openings in the heart's wall. They are implanted through minimally invasive procedures, offering an effective and less invasive alternative to open-heart surgery for patients with these defects.

The primary types of heart defect closure devices include atrial septal defect (ASD) closure devices, left atrial appendage (LAA) closure devices, patent foramen ovale (PFO) closure devices, patent ductus arteriosus (PDA) closure devices, and ventricular septal defect (VSD) closure devices. An ASD closure device is specifically designed to seal a hole in the wall between the heart's two upper chambers. These devices are constructed from various materials such as nitinol and stainless steel and can be delivered through transcatheter, surgical, and other delivery methods by hospitals, clinics, ambulatory surgical centers, and other healthcare facilities.

The heart defect closure device market research report is one of a series of new reports from The Business Research Company that provides heart defect closure device market statistics, including the heart defect closure device industry global market size, regional shares, competitors with heart defect closure device market share, detailed heart defect closure device market segments, market trends, and opportunities, and any further data you may need to thrive in the heart defect closure device industry. These heart defect closure device market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The heart defect closure device market size has grown rapidly in recent years. It will grow from $1.11 billion in 2024 to $1.27 billion in 2025 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to growing number of people with congenital heart problems, ageing population, rising health awareness, increasing R&D, and advancements in catheterization techniques.

The heart defect closure device market size is expected to see rapid growth in the next few years. It will grow to $2.17 billion in 2029 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to increasing congenital defects, improved diagnostic techniques, rise in adoption of MRI procedures, rise in use of 3d imaging in heart defect closure procedures, and high occurrence of ischemic stroke. Major trends in the forecast period include technological advancements, development of innovative products, development of next-generation heart closure devices, growing detection of PFO closure devices, and need to assess the benefits of PFO closure for the aged population.

The increasing prevalence of congenital heart problems is expected to drive the growth of the heart defect closure device market in the coming years. Congenital heart problems are structural defects in the heart present from birth. The rise in congenital heart issues can be attributed to factors such as genetic predispositions, environmental influences, and maternal health conditions like diabetes, obesity, and exposure to certain medications or infections during pregnancy. Heart defect closure devices provide minimally invasive solutions to treat these conditions by sealing abnormal heart openings, restoring normal blood flow, reducing complications, and enhancing overall cardiac function. For example, in October 2024, an article published in the National Library of Medicine (NLM), a US-based biomedical research organization, reported a sharp increase in the incidence rate of congenital heart disease (CHD) to 5.46% in 2023, up from 1.12% in 2020, 2.36% in 2021, and 3.87% in 2022. As a result, the growing number of individuals with congenital heart problems is driving the expansion of the heart defect closure device market.

Major companies in the heart defect closure device market are developing self-expanding, double-disc occluders to provide minimally invasive solutions for sealing heart defects. These occluders enhance procedural safety, improve patient outcomes by reducing recovery times, and minimize the risk of complications associated with traditional open-heart surgeries. For example, in September 2022, Abbott Laboratories, a US-based medical devices and healthcare company, launched the Amplatzer Talisman PFO Occlusion System in Europe. This device is designed to close a patent foramen ovale (PFO), an abnormal opening between the left and right atria of the heart that can lead to strokes and other complications. The system uses a minimally invasive procedure to deploy a self-expanding, double-disc occluder made of nitinol wire mesh, effectively sealing the PFO and preventing the passage of clots between the atria.

In February 2023, Boston Scientific Corporation, a US-based medical device manufacturer, acquired a 65% stake in Acotec Scientific Holdings Limited for $0.523 billion. This acquisition enhances Boston Scientific Corporation's position in China and enables the global commercialization of Acotec Scientific Holdings Limited's products. Acotec Scientific Holdings Limited is a China-based medical device company specializing in the interventional treatment of vascular diseases.

Major players in the heart defect closure device market are Abbott Laboratories, Medtronic, Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences, W L Gore and Associates, B. Braun, BIOTRONIK SE & Co. KG, Lepu Medical Technology, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, AtriCure Inc., LifeTech Scientific Corporation, Baylis Medical Company Inc., Biosense Webster Inc., Sahajanand Medical Technologies Limited, Occlutech, Coherex Medical Inc., Cardia Inc., Acrostak Corporation, Vivasure Medical, Transmural Systems Inc., Cormatrix Cardiovascular Inc., and St. Jude Medical LLC.

North America was the largest region in the heart defect closure device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart defect closure device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the heart defect closure device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The heart defect closure device market consists of sales of amplatzer septal occluder, gore cardioform septal occluder, and HELEX septal occluder. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Heart Defect Closure Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on heart defect closure device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for heart defect closure device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The heart defect closure device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Heart Defect Closure Device Market Characteristics

3. Heart Defect Closure Device Market Trends And Strategies

4. Heart Defect Closure Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Heart Defect Closure Device Growth Analysis And Strategic Analysis Framework

6. Heart Defect Closure Device Market Segmentation

7. Heart Defect Closure Device Market Regional And Country Analysis

8. Asia-Pacific Heart Defect Closure Device Market

9. China Heart Defect Closure Device Market

10. India Heart Defect Closure Device Market

11. Japan Heart Defect Closure Device Market

12. Australia Heart Defect Closure Device Market

13. Indonesia Heart Defect Closure Device Market

14. South Korea Heart Defect Closure Device Market

15. Western Europe Heart Defect Closure Device Market

16. UK Heart Defect Closure Device Market

17. Germany Heart Defect Closure Device Market

18. France Heart Defect Closure Device Market

19. Italy Heart Defect Closure Device Market

20. Spain Heart Defect Closure Device Market

21. Eastern Europe Heart Defect Closure Device Market

22. Russia Heart Defect Closure Device Market

23. North America Heart Defect Closure Device Market

24. USA Heart Defect Closure Device Market

25. Canada Heart Defect Closure Device Market

26. South America Heart Defect Closure Device Market

27. Brazil Heart Defect Closure Device Market

28. Middle East Heart Defect Closure Device Market

29. Africa Heart Defect Closure Device Market

30. Heart Defect Closure Device Market Competitive Landscape And Company Profiles

31. Heart Defect Closure Device Market Other Major And Innovative Companies

32. Global Heart Defect Closure Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Heart Defect Closure Device Market

34. Recent Developments In The Heart Defect Closure Device Market

35. Heart Defect Closure Device Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â